Skip to main content

Kai Sun

Associate Professor of Medicine
Medicine, Rheumatology and Immunology

Overview


My clinical interests are in general rheumatology, lupus, and musculoskeletal ultrasound. My research interest is in healthcare disparities and medication adherence in rheumatology.

Current Duke Appointments & Affiliations


Associate Professor of Medicine · 2025 - Present Medicine, Rheumatology and Immunology, Medicine
Associate Professor in Population Health Sciences · 2025 - Present Population Health Sciences, Basic Science Departments

Recent News Items


Published August 12, 2021
RheumatologyAdvisor
Poor Patient-Provider Communication and Low Patient Self-Efficacy Linked to SLE-Related Damage in African American Patients
Published June 17, 2021
AARP
5 Lupus Warning Signs You Should Know
Published April 9, 2021
RheumtologyAdvisor
Addressing Barriers to Lupus Medication Uptake in Minority Patients, With Kai Sun, MD

View All News Items

Recent Scholarly Works


A quality improvement project to incorporate the mycophenolate Risk Evaluation and Mitigation Strategies in an academic lupus clinic

Conference Lupus · August 1, 2026 Background/Purpose: Mycophenolate compound (MMF, to represent both mycophenolate mofetil and mycophenolic acid) is an immunosuppressant used to treat Systemic Lupus Erythematosus (SLE). Due to its teratogenicity, the FDA recommends universal mycophenolate ... Full text Cite

A quality improvement project to incorporate the mycophenolate Risk Evaluation and Mitigation Strategies in an academic lupus clinic.

Journal article Lupus · August 2026 Background/PurposeMycophenolate compound (MMF, to represent both mycophenolate mofetil and mycophenolic acid) is an immunosuppressant used to treat Systemic Lupus Erythematosus (SLE). Due to its teratogenicity, the FDA recommends universal mycophenolate Ri ... Full text Link to item Cite

Differences in Self-Reported Medication Nonadherence and Its Drivers in Young Adults Versus Older Adults With Systemic Lupus Erythematosus.

Journal article J Rheumatol · April 1, 2026 OBJECTIVE: Medication adherence poses a challenge for young patients with systemic lupus erythematosus (SLE), who experience more active disease and damage than their older counterparts. This study aimed to quantify the rate of medication nonadherence by a ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


Evaluation of a Lupus Nephritis Care Pathway Integrating Telemedicine and Clinical Pharmacist Practitioners

ResearchPrincipal Investigator · Awarded by Rheumatology Research Foundation · 2026 - 2028

Improving patient-provider communication and medication adherence in systemic lupus erythematosus

ResearchPrincipal Investigator · Awarded by National Institute on Minority Health and Health Disparities · 2023 - 2028

Validation of a Pediatric DOSE Survey to Assess Medication Adherence

ResearchCollaborator · Awarded by Lupus Foundation of America · 2025 - 2026

View All Grants

Education


Washington University, School of Medicine · 2011 M.D.